Loading...
OTCM
ZHJLF
Market cap816mUSD
, Last price  
USD
Name

Zhong Ji Longevity Science Group Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-33.39%
Rev. gr., 5y
2.95%
Revenues
169m
+159.47%
1,055,932,8640000052,958,00034,720,00029,693,00065,165,000102,490,000555,386,000273,347,000180,048,000145,846,00080,022,00061,119,00089,668,00064,989,000168,626,000
Net income
-35m
L
-61,303,4243,561,6370000-134,081,00062,283,00075,597,000-26,008,000-148,282,000321,907,00082,274,000-2,199,094,000-825,969,000-10,700,0006,055,000701,0002,313,000-34,726,000
CFO
0k
-100.00%
-3,924,53600000-369,357,000222,736,000-98,372,000-125,552,000-88,516,00046,894,000-107,598,000214,190,000-17,926,000-198,703,000-41,212,00011,964,00015,279,0000

Profile

Zhong Ji Longevity Science Group Limited, an investment holding company, engages in the money lending business in Hong Kong and Mainland China. The company is involved in the provision of diagnostic consultation, and health and medical testing and checking services, as well as distribution of healthcare supplements. It also engages in the holding of equity investments; investment in short and long-term financial assets; provision of financial and investment consulting activities; and investment in properties. In addition, it offers health consulting services; and trades in medical products. The company was formerly known as Asia Pacific Silk Road Investment Company Limited and changed its name to Zhong Ji Longevity Science Group Limited in March 2021. Zhong Ji Longevity Science Group Limited was incorporated in 1994 and is headquartered in Causeway Bay, Hong Kong.
URL
IPO date
Nov 20, 1995
Employees
33
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
168,626
159.47%
64,989
-27.52%
89,668
46.71%
Cost of revenue
82,752
83,958
49,787
Unusual Expense (Income)
NOPBT
85,874
(18,969)
39,881
NOPBT Margin
50.93%
44.48%
Operating Taxes
1,595
2,222
8,622
Tax Rate
1.86%
21.62%
NOPAT
84,279
(21,191)
31,259
Net income
(34,726)
-1,601.34%
2,313
229.96%
701
-88.42%
Dividends
Dividend yield
Proceeds from repurchase of equity
14,567
BB yield
Debt
Debt current
15,988
11,762
Long-term debt
15,396
1,472
Deferred revenue
Other long-term liabilities
125,492
Net debt
(47,842)
(55,538)
(46,835)
Cash flow
Cash from operating activities
15,279
11,964
CAPEX
(1,030)
Cash from investing activities
382
16,587
Cash from financing activities
6,024
(7,454)
FCF
88,758
(30,200)
22,335
Balance
Cash
47,842
81,075
60,069
Long term investments
5,847
Excess cash
39,411
83,673
55,586
Stockholders' equity
400,139
(837,747)
31,277
Invested Capital
486,220
1,288,409
385,803
ROIC
9.50%
7.37%
ROCE
16.34%
9.55%
EV
Common stock shares outstanding
507,349
1,546,641
1,516,911
Price
Market cap
EV
EBITDA
85,874
(11,635)
44,089
EV/EBITDA
Interest
1,936
417
Interest/NOPBT
1.05%